Research and Development

Showing 15 posts of 9607 posts found.

board_peter_chambre

immatics appoints Peter Chambré as chairman

November 12, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Peter Chambre, immatics

Biotech development firm immatics has announced the appointment of Peter Chambré as chairman of the Board. Chambré has had extensive …
stephen whitehead image

Pharma treated as though ‘selling cyanide’

November 9, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, Stephen Whitehead

APBI chief executive Stephen Whitehead claimed that pharma companies are sometimes made to feel as though they are manufacturing poison …

Astellas appoints VP of Scientific and Medical Affairs

November 9, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Astellas, Jeffrey Bloss

Astellas has announced Jeffrey Bloss has joined the company as vice president of its Scientific and Medical Affairs (ASMA) division. …
speakerwilliamsmarth

Leadership changes at Teva

November 8, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Levin, Teva

Teva Pharmaceutical has announced some management changes to its executive leadership team. Allan Oberman, senior vice president of North America …
janssen image

Janssen and GSK in hep C tie-ups

November 8, 2012 Research and Development, Sales and Marketing GSK, Janssen, Vertex, hep C

Janssen and GlaxoSmithKline are to conduct separate Phase II studies with Vertex Pharmaceuticals to test an investigational all-oral regimen to …
bad pharma image

Goldacre is right – greater honesty is needed

November 7, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, Les Rose

One of the most trenchant critics of pseudo-science in healthcare, the neuro-psychologist Dr Ben Goldacre, has turned his guns on …
screen_shot_2012-11-07_at_10

Sanofi’s chief executive new president elect of EFPIA

November 7, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Viehbacher, Sanofi

European pharma members body the EFPIA has announced that Sanofi’s chief executive Christopher Viehbacher is to stand as its new …
Takeda HQ image

Takeda to buy Envoy Therapeutics

November 7, 2012 Research and Development, Sales and Marketing CNS, Envoy, Parkinson's, Parkinsons, Takeda

Takeda Pharmaceutical Company has bought another private US firm, its second in as many months. The Japanese group is paying …
Pfizer Sandwich image

Pfizer backs new biotech firm

November 6, 2012 Research and Development, Sales and Marketing Pfizer, Sandwich, Ziarco

Pfizer is one of the main backers of new biotech company Ziarco, launched by four of the manufacturer’s ex-employees. The …
goldrick

First Northern Ireland director for ABPI announced

November 6, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Colette Goldrick, Ireland

The ABPI has confirmed the appointment of Colette Goldrick as its new Northern Ireland director and as a member of …

Pfizer stumbles in third quarter

November 2, 2012 Research and Development, Sales and Marketing Ian Read, Lipitor, Pfizer, Prevnar, Q3

Pfizer has experienced a worse than expected third quarter, due to disappointing sales of paediatric vaccine Prevnar and a surprise …
screen_shot_2012-11-02_at_09

COPA-DATA appoints new UK managing director

November 2, 2012 Manufacturing and Production, Research and Development, Sales and Marketing COPA-DATA, Martyn Williams

Ergonomic process solutions firm COPA-DATA has appointed Martyn Williams as UK managing director with immediate effect. A qualified electronic engineer, …

Lilly appoints new chief ethics and compliance officer and senior VP

October 30, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Melissa Barnes, lilly

Eli Lilly has announced that Melissa Barnes will be promoted to chief ethics and compliance officer and senior vice president …

Shionogi and ViiV strike new HIV deal

October 30, 2012 Research and Development, Sales and Marketing Atripla, Dolutegravir, HIV, Shionogi, ViiV

HIV specialist firm ViiV Healthcare has announced a new deal with Japan’s Shionogi on a promising new treatment. ViiV Healthcare …

Pharmalink AB strengthens senior management

October 30, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Heather Cook, Marek Poszepczynski, Pharmalink AB

Pharmalink AB has appointed Heather Cook as director of Regulatory Affairs and Marek Poszepczynski as director of Business Development. Cook …
The Gateway to Local Adoption Series

Latest content